CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$53.91 USD
+0.18 (0.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $53.50 -0.41 (-0.76%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For CRSP
-
CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
-
CRISPR (CRSP) Q4 Earnings Top on Collaboration Revenues, Stock Up
-
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?
-
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
CRISPR Therapeutics AG (CRSP) Up 20.5% Since Last Earnings Report: Can It Continue?
-
CRISPR Therapeutics (CRSP) Q3 Loss Narrower Than Expected
-
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
-
Will CRISPR Therapeutics AG (CRSP) Report Negative Q3 Earnings? What You Should Know
-
CRISPR (CRSP) to Report Q3 Earnings: What's in the Cards?
-
CRISPR Therapeutics AG (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?
-
CRISPR Therapeutics (CRSP) Q2 Loss Narrower Than Expected
-
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates
-
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
-
CRISPR (CRSP) to Post Q2 Earnings: What's in the Offing?
-
Why Is CRISPR Therapeutics AG (CRSP) Up 1.8% Since Last Earnings Report?
-
CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat
-
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Tops Revenue Estimates
-
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
-
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
-
CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
-
CRISPR (CRSP) Q4 Earnings Surpass Estimates, Sales Miss
-
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Misses Revenue Estimates
-
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?